Skip to main content
. 2017 Oct 26;35(35):3942–3948. doi: 10.1200/JCO.2017.74.1165

Fig 1.

Fig 1.

Flow of participants of NSABP (National Surgical Adjuvant Breast and Bowel Project) B-31 long-term cardiac follow-up. AC, doxorubicin and cyclophosphamide; H, trastuzumab; LTF, long-term follow-up; MUGA, multigated acquisition; P, paclitaxel; PRO, patient-reported outcome.